GLIOMA, MALIGNANT
Clinical trials for GLIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new GLIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for GLIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor patients get experimental virus injection in new trial
Disease control Not yet recruitingThis early-stage trial tests a modified herpes virus (C5252) injected into the brain tumor cavity of 36 adults with recurrent high-grade glioma who have no other treatment options. The goal is to see if the virus is safe, tolerable, and can help patients live longer. Participants…
Matched conditions: GLIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New hope for brain cancer? experimental drug LMP744 targets recurrent glioblastoma
Disease control Not yet recruitingThis early-stage trial tests a new drug called LMP744 in 40 adults whose glioblastoma (a type of brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days each month for up to a year. The goal is to see if it can shrink tumors or delay canc…
Matched conditions: GLIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated May 11, 2026 20:49 UTC